Comparison and consideration of vaccine injury compensation programs in the Republic of Korea, Japan, and Taiwan
10.24171/j.phrp.2024.0129
- Author:
Cho Ryok KANG
1
;
Young June CHOE
;
Jihyun MOON
;
Dooyoung KIM
;
Taemi KIM
;
Jong-Koo LEE
Author Information
1. Allergy and Immunology Center, Korea University, Seoul, Republic of Korea
- Publication Type:Review Article
- From:
Osong Public Health and Research Perspectives
2024;15(6):479-488
- CountryRepublic of Korea
- Language:English
-
Abstract:
This study aimed to establish a foundation for future collaborations aimed at preparing for and responding to infectious diseases by examining the vaccine injury compensation programs (VICPs) of East Asian countries. We reviewed the current status of VICPs in the Republic of Korea, Japan, and Taiwan by searching national government websites and reviewing relevant literature. Additionally, we conducted email inquiries targeting experts from Japan and Taiwan.Through the comprehensive analysis of VICPs in these 3 countries covered various aspects,we identified several similarities and differences in the VICPs across these countries. Whilethe governments of the Republic of Korea, Japan, and Taiwan play a central role in supporting investigations into vaccine injuries and managing compensation procedures based on legalstatutes, they differ in terms of financial resources for compensation, the range of vaccinescovered, and the criteria for assessing causality. In the Republic of Korea, Japan, and Taiwan,compensation is typically paid in a lump sum, although the specific benefits available vary bycountry. This study on VICPs in the Republic of Korea, Japan, and Taiwan provides valuable insights for the further development and management of domestic systems.
